Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

DOXORUBICIN How Supplied/Storage and Handling (doxorubicin hydrochloride)

16 HOW SUPPLIED/STORAGE AND HANDLING

Doxorubicin Hydrochloride Injection

Doxorubicin Hydrochloride Injection is a sterile, isotonic solution, available in polypropylene (CYTOSAFE)® vials in single vial packs as:

Single-dose Vials

 
10 mg/5 mL (2 mg/mL) NDC 0069-3030-20
 
20 mg/10 mL (2 mg/mL) NDC 0069-3031-20
 
50 mg/25 mL (2 mg/mL) NDC 0069-3032-20

Retain in carton until time of use. Discard unused portion.

Multiple-dose Vials

 
150 mg/75 mL (2 mg/mL) NDC 0069-3033-20
 
200 mg/100 mL (2 mg/mL) NDC 0069-3034-20

Retain in carton until contents are used.

Storage

Store all vials at 2° to 8°C (36° to 46°F). Protect from light.

Storage of Doxorubicin Hydrochloride Injection under refrigerated conditions can result in the formation of a gelled product. Place gelled product at room temperature [15° to 30°C (59° to 86°F)] for 2 to 4 hours to return the product to a slightly viscous, mobile solution.

Handling and Disposal

Doxorubicin Hydrochloride Injection is a cytotoxic drug. Follow applicable special handling and disposal procedures.1

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event